About Lexington BioSciences
Lexington BioSciences was a publicly listed company based in Reno (United States) founded in 2015. It creates innovative non-invasive vascular monitoring devices. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Healthcare and Biotechnology, Medical Devices, Monitoring Devices and Non-Invasive Vascular Monitoring. Similar companies include Edwards Lifesciences, BioIntelliSense and Endotronix; 2 of its 3 listed similar companies have raised funding.
Company details
Lexington BioSciences creates innovative non-invasive vascular monitoring devices, focusing on healthcare and biotechnology, developing medical devices, monitoring devices, and non-invasive vascular monitoring. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Reno, United States
- Stage Public
- SectorsHealthcare
- Website lexingtonbiosciences.com/cgi-sys/suspendedpage.cgi
- Social X
- Legal Name Lexington Biosciences Inc
- Net Profit-$256.34 K (USD)32.05as on Dec 31, 2021
- EBITDA-$256.34 K (USD)32.05as on Dec 31, 2021
- Latest Funding Round$1.65M (USD), Post-IPO
Dec 2017
Funding Insights of Lexington BioSciences
- Total Rounds 1
- Last Round Post-IPO — $1.65M
- First Round $1.65M
(Dec 2017)
All 1 funding rounds of Lexington BioSciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2017 | $1.65M | Post-IPO | – | – | – |
People of Lexington BioSciences
5 people are tracked at Lexington BioSciences (2 in leadership, 3 in board & advisors).
| Name | Role | Group |
|---|---|---|
Eric Willis | President | Leadership |
Jonathan S. Maltz | Chief Scientific Advisor | Leadership |
Donald A. Mcinnes | Advisor | Board & advisors |
Doug Janzen | Board Chairman | Board & advisors |
Bryan Disher | Director | Board & advisors |
Complete people profiles for Lexington BioSciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Lexington BioSciences
Lexington BioSciences is a publicly listed company on the OTC with ticker symbol LXGTF in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date21 Jul 2017
- Listed onOTCMKTS: LXGTF
- Listed entityLEXINGTON BIOSCIENCES INC
- Exchange sectorHealth technology
- ISINCA5290204067
- Share price$0.00 (-99% on the day) · 2026-10-06
- Volume (last session)40,011
Financials of Lexington BioSciences
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2021 | -$256,340 | -$256,340 | |
| 2020 | -$377,250 | -$377,250 |
Detailed financial statements for Lexington BioSciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Lexington BioSciences
3 dated milestones of Lexington BioSciences across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Lexington BioSciences is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $1.6M.
Similar companies to Lexington BioSciences
Lexington BioSciences has 3 listed similar companies in our database, 2 of them funded. They include Edwards Lifesciences, BioIntelliSense and Endotronix.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| edwards.com | 1958 | Irvine, United States | 19,800 | Medical devices for structural heart disease are developed and provided. | ||
| biointellisense.com | 2018 | Redwood, United States | $82M | 26 | Vital signs are monitored via a single-use patch and platform. | |
| endotronix.com | 2007 | East Peoria, United States | $154.77M | 104 | Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. |
Detailed similar companies of Lexington BioSciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Health Monitoring & Wearables
3 companies that operate in the same segment as Lexington BioSciences (Health Monitoring & Wearables) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lexington Biosciences
Complete news archive for Lexington BioSciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lexington BioSciences
Lexington BioSciences was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Lexington BioSciences is headquartered in Reno, United States. It is registered at Reno, Nevada, United States.
Lexington BioSciences creates innovative non-invasive vascular monitoring devices, focusing on healthcare and biotechnology, developing medical devices, monitoring devices, and non-invasive vascular monitoring. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Lexington BioSciences's top competitors include Endotronix, BioIntelliSense and Edwards Lifesciences.
Yes, Lexington BioSciences is publicly traded on OTC under the ticker symbol LXGTF.